Open Evidence, in consortium with BrainSigns, BDI Research, and London School of Economics (LSE) will lead a new study for the European Commission (EIOPA, CHAFEA) on the implications of Covid-19 in relation with travel insurance products, with particular focus on the impact the global pandemic had on consumer behaviours in acquisition, usage, and disposition decisions. The consortium will provide the evidence base needed to enable informed policy making in the area of travel insurance.
To address the objectives of this study the team will use a mixed methods approach, where different methods, instruments and sources will be triangulated. The combined use of these different techniques will ensure that both the generic and the more specific research questions are addressed. The study will consist first in a literature review to identify and analyse previous research on the topics, and then in three different fieldwork activities to gather fresh data to enrich the analysis. Online focus groups with 6 participants will be conducted in Italy, Germany and Romania. An eye-tracking neuroscientific experiment will follow, assessing where participants look for information and what they consider relevant or confusing when reading travel insurance T&C. It will be conducted in the same three countries as the focus groups, with a sample of 100 participants each. Finally, an online Discrete Choice Experiment (DCE) where participants will be asked to select an insurance package for a hypothetical upcoming trip will be conducted in Italy, Germany, Romania, Finland, Hungary, and Greece, with a sample of 1000 participants for each country. All the data gathered will be triangulated and will provide strong evidence supporting the policy recommendations we will present to the client by the end of the study, expected to come by the last quarter of 2021.